Benzinga | Jul 23, 2020 05:24AM EDT

Needham Upgrades Surmodics to Buy, Announces $61 Price Target

Needham analyst Mike Matson upgrades Surmodics (NASDAQ:SRDX) from Hold to Buy and announces $61 price target.